Original Query: pazopanib GIST
Previous Study | Return to List | Next Study

Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (PAGIST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01524848
Recruitment Status : Completed
First Posted : February 2, 2012
Last Update Posted : May 10, 2017
Information provided by (Responsible Party):
Scandinavian Sarcoma Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2015
  Study Completion Date : November 2016